| Product Code: ETC12463357 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Imatinib Drug Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Imatinib Drug Market - Industry Life Cycle |
3.4 Argentina Imatinib Drug Market - Porter's Five Forces |
3.5 Argentina Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Argentina Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Argentina Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Argentina Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Argentina Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Argentina Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Argentina |
4.2.2 Growing awareness about the effectiveness of imatinib in treating CML |
4.2.3 Favorable government policies promoting access to essential medications |
4.3 Market Restraints |
4.3.1 High cost of imatinib treatment leading to affordability issues |
4.3.2 Competition from generic imatinib drugs impacting market share |
4.3.3 Regulatory challenges and delays in drug approval processes |
5 Argentina Imatinib Drug Market Trends |
6 Argentina Imatinib Drug Market, By Types |
6.1 Argentina Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Argentina Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Argentina Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Argentina Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Argentina Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Argentina Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Argentina Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Argentina Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Argentina Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Argentina Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Argentina Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Argentina Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Argentina Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Argentina Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Argentina Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Argentina Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Argentina Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Argentina Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Argentina Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Argentina Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Argentina Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Argentina Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Argentina Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Argentina Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Argentina Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Argentina Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Argentina Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Argentina Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Argentina Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Argentina Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Argentina Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Argentina Imatinib Drug Market Import-Export Trade Statistics |
7.1 Argentina Imatinib Drug Market Export to Major Countries |
7.2 Argentina Imatinib Drug Market Imports from Major Countries |
8 Argentina Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of healthcare professionals trained in prescribing and managing imatinib treatment |
8.3 Rate of new clinical trials and research studies on imatinib efficacy and safety |
9 Argentina Imatinib Drug Market - Opportunity Assessment |
9.1 Argentina Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Argentina Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Argentina Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Argentina Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Argentina Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Argentina Imatinib Drug Market - Competitive Landscape |
10.1 Argentina Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Argentina Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here